GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » Institutional Ownership

Anterogen Co (XKRX:065660) Institutional Ownership : 0.73% (As of Jun. 09, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Anterogen Co's institutional ownership is 0.73%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Anterogen Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Anterogen Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Anterogen Co Institutional Ownership Historical Data

The historical data trend for Anterogen Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co Institutional Ownership Chart

Anterogen Co Historical Data

The historical data trend for Anterogen Co can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.60 0.61 0.64 0.65 0.57 0.65 0.72 0.73 0.73 0.73

Anterogen Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Anterogen Co (XKRX:065660) Business Description

Traded in Other Exchanges
N/A
Address
Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589
Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co (XKRX:065660) Headlines

No Headlines